← Leaderboards
Kristin E. Burke
Massachusetts General Hospital
$933,528
Attributed
$933,528
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $196.2K · FY2018–25$200K$150K$100K$50K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$933,528 · 2
By mechanism
K23$784,992 · 1
F32$148,536 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Charalabos Pothoulakis$14,967,772
- Robyn S Klein$18,056,082
- Michael Lawrence Dougan$4,403,010
- Atul K Bhan$6,915,510
- Ashwin N Ananthakrishnan$4,084,397
Others in their field
Other Emerging Leaders on “Quality Of Life”
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,912,072
- Martha Hering · Westat, Inc.$57,098,843
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Abraham Aizer Brody · New York University School Of Medicine$40,849,810
- Steven A. Ackerman · University Of Wisconsin-Madison$38,898,438
- Greg Yothers · University Of Chicago$35,003,821
Research focus
Quality Of LifeCohortMaintenanceUnited States National Institutes Of HealthMentorsEnvironmentGeneticInflammatory Bowel DiseasesPathway InteractionsTreatment ResponseProspectivePathogenesisInflammatoryCharacteristicsCareer DevelopmentCareerAffectButyratesAnti-Inflammatory AgentsDiagnosticDietColorectal CancerBlood SpecimenBiological
Grant awards (6)
Diet and metabolic factors in the pathogenesis of microscopic colitis$196,248
K23 · FY2025 · DK · contact PI
Diet and metabolic factors in the pathogenesis of microscopic colitis$196,248
K23 · FY2024 · DK · contact PI
Diet and metabolic factors in the pathogenesis of microscopic colitis$196,248
K23 · FY2023 · DK · contact PI
Diet and metabolic factors in the pathogenesis of microscopic colitis$196,248
K23 · FY2022 · DK · contact PI
Genetic and Clinical Predictors of Response to Anti-Tumor Necrosis Factor Therapy in Patients with Ulcerative Colitis$76,658
F32 · FY2019 · DK · contact PI
Genetic and Clinical Predictors of Response to Anti-Tumor Necrosis Factor Therapy in Patients with Ulcerative Colitis$71,878
F32 · FY2018 · DK · contact PI